News Wire
Marengo Asia Hospitals Signs MoU with Metropolitan Hospitals (Kenya) and Zoscales Partners (Switzerland) to Strengthen Healthcare Accessibility and Clinical Capacity Building in East Africa
NEW DELHI, Oct. 25, 2024 /PRNewswire/ — Marengo Asia Hospitals announces the signing of a Memorandum of Understanding (MoU) with Metropolitan Hospitals Limited (Kenya) and Zoscales Partners under its Clinical Corridor Initiative to build “Centre of Excellence” at the Metropolitan Hospital in Nairobi. This landmark collaboration aims to significantly improve healthcare accessibility and affordability in tertiary care across East Africa, addressing the urgent need for advanced healthcare services in the region.
As an emerging leader in the healthcare sector, Marengo Asia Hospitals will leverage its extensive experience and expertise of clinical capabilities to empower Metropolitan Hospitals to become a regional hub for tertiary care for East Africa. This partnership will focus on establishing Centres of Excellence (CoEs) for chosen specialities, ensuring that high-quality healthcare is accessible to underserved communities.
“Marengo Asia Hospitals is proud to share its knowledge and best practices from India to support Metropolitan Hospitals in expanding access to world-class healthcare in East Africa. Marengo Asia Hospitals is a strong proponent of the concept of building Clinical Corridors across geographies. This is based on the principles of 3 Ts (Teach, Train and Treat) in elevating healthcare standards globally. We are committed to capacity building, advancing healthcare standards and fostering collaboration across boundaries. With a rich history in establishing Centres of Excellence (CoEs) for healthcare providers globally, we have set up CoEs in cardiology, oncology, and transplants in Mongolia, and Asia Pacific, fostering international collaboration and advancing healthcare capabilities,” said Dr. Raajiv Singhal, Founding Member, Managing Director, and CEO of Marengo Asia Hospitals. “Our holistic approach in developing Centres of Excellence includes teams planning, infrastructure, compliance, development of pathways protocols, and training for all department stakeholders,” he added.
“By upgrading our clinical services and expanding access to advanced healthcare, we are not only improving the quality of care but also making it more affordable and accessible to a broader population,” said Dr. K. K. Gakombe, Founder and CEO of Metropolitan Hospitals Limited. “This partnership with Marengo Asia Hospitals and Zoscales Partners enables us to significantly expand our reach and amplify our positive impact,” he added.
“This partnership underscores our commitment to making a meaningful difference where it matters most—improving access to quality healthcare,” said Jacop B. Rentschler, Co-Founder and Managing Partner at Zoscales Partners. “By combining Marengo Asia Hospitals’ world-class expertise with Metropolitan Hospitals’ local strength, we are building a transformative platform that will boost clinical capacity and expand sustainable healthcare access for communities across East Africa,” he concluded.
Marengo Asia Hospitals has a strong track record of impactful collaborations through its innovative concept of ‘Clinical Corridors.’ For instance, Marengo Asia Hospitals recently entered into a multi-year agreement with Intermed Hospital in Mongolia to establish the country’s first comprehensive Cardiac Sciences Centre of Excellence. This groundbreaking initiative aims to provide advanced cardiac treatments and specialized care to the Mongolian population, addressing a critical need for high-quality healthcare services. Together, Marengo Asia Hospitals, Metropolitan Hospitals, and Zoscales Partners are forging a powerful alliance to build a sustainable healthcare framework that will enhance the well-being of communities across East Africa. This collaboration reaffirms Marengo Asia Hospitals’ mission to transform healthcare and ensure that quality medical services are available to everyone.
About Marengo Asia Hospitals:
Marengo Asia Hospitals is an integrated network of multi-specialty hospitals dedicated to providing tertiary and quaternary care. The organization focuses on creating ‘centres of excellence‘ across various medical specialties while prioritizing a ‘patient-first’ approach. Under the leadership of Dr. Raajiv Singhal, the Founding Member, Managing Director, and Group CEO, Marengo Asia Hospitals has rapidly expanded to a capacity of over 1,700 beds across five hospitals, supported by a team of more than 600 skilled doctors. In its pursuit of excellence, Marengo Asia Hospitals has embarked on a mission to create Clinical Centres of Excellence that set new standards for healthcare quality, innovation, and measurable outcomes. The organization’s goal is not just to provide healthcare services but to elevate the entire healthcare experience for patients and their families. Marengo Asia Hospitals is also proud to advance the International Clinical Corridor—an innovative collaboration between its experts and the health ministries of partner countries to establish Centres of Excellence (CoE) for specific medical specialties. Through this initiative, doctors, nurses, and healthcare staff from partner countries receive comprehensive training in India, equipping them with advanced skills to enhance healthcare services in their home countries. Marengo Asia Hospitals is committed to fostering an environment of healing, innovation, and trust, serving as a cornerstone of health and wellness in the communities it serves.
Metropolitan Hospitals Limited is a Level 5 facility located in Buruburu, in the Eastlands area of Nairobi County. Over the past 30 years, the hospital has evolved into Eastlands’ premier medical hub, featuring state-of-the-art facilities such as an ultramodern doctor’s plaza, a fully equipped Accident and Emergency department, advanced modular theatres, an Intensive Care Unit (ICU), Neonatal ICU, High Dependency Unit (HDU), and comprehensive Imaging and Laboratory services. Metropolitan is accredited by the Council for Health Service Accreditation (COHSASA) for maintaining quality standards. Committed to delivering high-quality, affordable care, the hospital has bold plans for regional expansion, reinforcing its dedication to excellence and accessibility.
Zoscales Partners, founded in 2014, is a Swiss-based investment management firm specializing in high-impact investments across Eastern Africa. With regional offices in Ethiopia and Kenya, Zoscales Partners is committed to driving sustainable development through investments that deliver long-term value and tangible improvements in healthcare and other essential sectors.
For more information, please contact:
Megha Chhabra
Marengo Asia Hospitals
megha.chhabra@marengoasia.com
+91 9990997421
View original content to download multimedia:https://www.prnewswire.com/in/news-releases/marengo-asia-hospitals-signs-mou-with-metropolitan-hospitals-kenya-and-zoscales-partners-switzerland-to-strengthen-healthcare-accessibility-and-clinical-capacity-building-in-east-africa-302286876.html
News Wire
Reliance Digital Introduces High-Performance iQOO 15R to its Nationwide Store Network
MUMBAI, India, March 11, 2026 /PRNewswire/ — Reliance Digital announces the offline retail availability of iQOO, the high-performance smartphone brand built for today’s youth and tech-forward consumers. Following strong traction in online channels, iQOO is now extending its presence into physical retail, allowing customers to experience and purchase its devices first-hand at Reliance Digital stores across India.
Known for pushing the boundaries of speed, and power, the iQOO 15R is powered by the Snapdragon 8 Gen 5, delivering exceptional speed, responsiveness, and sustained performance throughout the day. It packs iQOO’s biggest battery yet in an ultra-slim 7.90mm design, making it India’s slimmest smartphone with a 7600 mAh battery.
The device features a 6.5K IceCore VC Cooling Chamber for stable performance and runs on OriginOS 6.0 based on Android 16 out of the box, supported by 4 years of software updates and 6 years of security updates. It is also equipped with a Sony LYT-700V OIS camera, a 1.5K 144Hz AMOLED EyeCare display, and IP68 & IP69 dust and water resistance, making it a dependable daily partner for professionals on the go.
The brand’s offline expansion marks an important step in deepening consumer engagement by offering hands-on access to its devices, enabling customers to explore iQOO’s powerful performance, advanced display technology, and flagship-grade camera capabilities in a real-world retail environment.
The availability of iQOO at Reliance Digital brings together two brands driven by innovation and consumer experience. While iQOO continues to build its reputation as a performance-led smartphone brand, Reliance Digital strengthens its portfolio by offering customers access to cutting-edge technology brands through its extensive nationwide retail network.
Through engaging in-store experiences, knowledgeable staff, and immersive product demonstrations, Reliance Digital aims to help consumers better understand iQOO’s performance-first DNA. This move further reinforces Reliance Digital’s commitment to staying ahead of evolving consumer preferences and serving as a preferred destination for discovering new-age technology.
With this expansion, Reliance Digital continues to play a key role in shaping India’s consumer electronics landscape by bringing future-ready brands closer to customers, while enabling smartphone brands like iQOO to build stronger connections with a growing, performance-driven audience.
The all new iQOO 15R is now available at Reliance Digital stores nationwide.
View original content to download multimedia:https://www.prnewswire.com/in/news-releases/reliance-digital-introduces-high-performance-iqoo-15r-to-its-nationwide-store-network-302711079.html
News Wire
Kotak Alts announces winner of the inaugural Katalyst Awards
Ms Himani Choudhary named Katalyst for the year – India’s Best Financial Content Creator; wins Rs. 25 Lakhs
MUMBAI, India, March 10, 2026 /PRNewswire/ — Kotak Katalyst Awards, a national initiative instituted to recognise excellence and responsibility in financial content creation has announced the winner of its first Katalyst edition. Kotak Alternate Asset Managers Limited (“Kotak Alts”) today announced Himani Choudhary as the winner. The winner was awarded a prize of INR 25 Lakhs, positioning Katalyst among the most meaningful recognitions for financial content creators in India.
Srini Sriniwasan, Managing Director, Kotak Alts, said, “The Kotak Alts Katalyst Awards were instituted to recognize content creators who are contributing meaningfully to financial literacy in India. As investor participation deepens, audiences are seeking clarity, context, and credibility. The response from creators was overwhelming and points to the new generation of financial educators. As the inaugural winner Ms. Himani Chaudhary, exemplifies the standard of financial communication that Katalyst seeks to encourage.”
The first edition of the Kotak Alts Katalyst Awards received over six hundred entries from across 19 states and in 8 languages, reflecting the growing role of digital creators in shaping financial awareness. Conceived in response to increasing clutter and misinformation in the financial ecosystem, Katalyst is designed to recognize creators who place accuracy, transparency, and investor interest at the core of their work.
The winning content, ‘Personal Finance & Major Finance Updates’ by Himani Choudhary, was recognised for its clarity, originality, and credibility. The jury noted the content’s ability to explain complex financial concepts in a clear and measured manner, supported by strong research and a consistent focus on investor education over virality.
To ensure a robust and transparent evaluation process, the awards framework was designed and audited by EY. The top thirty entries were assessed by an academic jury.
The top 10 finalists were subsequently evaluated by a grand jury comprising Kunal Shah, Founder and CEO of CRED; Radhika Gupta, Managing Director and CEO of Edelweiss Mutual Fund; and Alpesh Shah, Managing Director and Senior Partner at Boston Consulting Group, and chaired by Ananth Narayan, former Whole–Time Member of SEBI with extensive capital markets and regulatory experience.
The Katalyst Awards recognise financial content creators who priorities financial literacy, substance, and long–term investor interest. Through this initiative, Kotak Alts aims to encourage responsible financial communication and support the development of informed and confident investors across India.
About Kotak Alternate Asset Managers Ltd: Kotak Alternate Asset Managers Limited (‘Kotak Alts’), a part of Kotak Mahindra Group (‘Kotak’), focuses on Alternate Asset Management and Investment Advisory businesses. Kotak Alts was set up in early 2005 and has raised, managed, and advised over USD 22 billion across different asset classes, including Private Equity, Real Estate, Infrastructure, Special Situations, Private Credit, and Investment Advisory. The asset management business and investment advisory vertical are managed by independent specialist teams. For more information, visit https://www.kotakalternateasset.com/
View original content to download multimedia:https://www.prnewswire.com/in/news-releases/kotak-alts-announces-winner-of-the-inaugural-katalyst-awards-302709187.html
News Wire
Paperpal for Life Sciences Establishes HIPAA Readiness, Strengthening Enterprise Adoption of AI in Regulated Medical and Scientific Writing Workflows
MUMBAI, India, March 10, 2026 /PRNewswire/ — Paperpal for Life Sciences, an enterprise-grade Artificial Intelligence (AI) platform by Cactus Communications, purpose-built for Medical Affairs and Life Sciences organizations, announced the completion of an assessment evaluating its operational and technical safeguards to support Health Insurance Portability and Accountability Act (HIPAA) requirements. This milestone reinforces Paperpal’s commitment to meeting the rigorous standards of security, data protection, and regulatory readiness required for regulated scientific workflows.
Growing AI use in medical affairs writing and publication workflows is intensifying scrutiny on data privacy, governance, and regulatory accountability. To support these evolving needs, Paperpal for Life Sciences has undertaken an assessment of its systems and processes to evaluate readiness to support HIPAA compliance, where applicable, and now proudly offers the option to execute a Business Associate Agreement (BAA) for Protected Health Information (PHI) and Personally Identifiable Information (PII). This offering gives customers the confidence that PHI or PII, if received, is handled securely and responsibly, in line with regulatory expectations and enterprise risk management practices.
Paperpal for Life Sciences provides AI writing, literature search, source-grounded summarization with citation support, and critical publication checks, powering medical affairs content creation under stringent data privacy and governance controls. The platform accelerates research-to-publication timelines by upto 25%, supporting faster dissemination of clinical evidence and earlier commercialization of new drugs and therapies.
Nishchay Shah, Group CTO and EVP, Products and AI at Cactus Communications, said, “As AI becomes foundational to regulated scientific and medical workflows, compliance and trust are no longer optional. Paperpal for Life Sciences’ HIPAA readiness measures reflect our secure-by-design approach to AI, strong data governance framework, and alignment with real-world enterprise and regulatory requirements. This milestone enables organizations to adopt AI at scale with confidence that their data, processes, and compliance obligations are protected .”
Elvira Dsouza, President, Cactus Life Sciences, added, “Medical Affairs and Life Sciences teams operate in highly regulated environments where scientific rigor, data privacy, and compliance are non-negotiable. HIPAA readiness positions Paperpal for Life Sciences as a trusted AI partner, one that enables organizations to accelerate evidence generation and scientific communication without compromising regulatory integrity .”
With this announcement, Paperpal for Life Sciences reinforces its position as a purpose-built, enterprise-ready AI platform for medical affairs content generation that supports innovation while meeting the highest standards of privacy, ethics, and regulatory compliance.
Media Contact:
Nidhi Amin
nidhi.amin@cactusglobal.com
View original content to download multimedia:https://www.prnewswire.com/in/news-releases/paperpal-for-life-sciences-establishes-hipaa-readiness-strengthening-enterprise-adoption-of-ai-in-regulated-medical-and-scientific-writing-workflows-302708082.html
India Emerging as Stable Investment Anchor in Turbulent Global Economy, Say Investors at IGF Mumbai 2026
Reliance Digital Introduces High-Performance iQOO 15R to its Nationwide Store Network
Reliance Digital Introduces High-Performance iQOO 15R to its Nationwide Store Network
-
Buzz2 months agoGLOBAL PAY – A New Era in Oman’s Digital Payments Solution
-
Buzz1 month agoCASA BACARDÍ unveils its first Tropical Edition in Goa, celebrating music, culture and collective expression
-
Buzz2 months agoOTM 2026 Set to Bring the Global Travel Industry to Mumbai as India’s Outbound Market Accelerates
-
Buzz1 month agoNew report from Standard Chartered highlights optimistic corporate outlook on India’s energy transition
-
Buzz3 weeks ago70% of Indian Firms Say Cross-Border Trade Has Become Harder to Navigate
-
Buzz1 month ago‘Made in India – The story of Desh Bandhu Gupta, Lupin and Indian Pharma’ Book Launched in Mumbai
-
News Wire1 month agoShriram Life Insurance launches Zaroorat Jaisi, Policy Vaisi: A Fully AI-Created Ad Film Campaign featuring Rahul Dravid
-
Buzz1 month agoTHE LEELA CONCLUDES THE FOURTH SEASON OF #POLOINTHEPINKCITY WITH A CELEBRATION OF THE ROYAL SPORT, CULTURE AND REFINED LUXURY
You must be logged in to post a comment Login